Top Suppliers:I want be here
Related CAS#:
614756-40-0 98994-97-9
209003-60-1 1676077-85-2
1692226-71-3 1676069-23-0
1355237-48-7 1361504-76-8
1602798-56-0 1566149-63-0

97-56-3

97-56-3 structure
97-56-3 structure
Name 2-Methyl-5-(p-tolyldiazenyl)aniline
Synonyms somaliayellowr
tulabasefastgnetgbc[qr]
organolyellow2t[qr]
2-Methyl-4((2-methylphenyl)azo)benzenamine
Waxakol Yellow NL
2-Methyl-4-([2-methylphenyl]azo)benzeneamine
2-methyl-4-(o-tolyldiazenyl)benzenamine
Toluene, o-aMinoazobenzene
Tulabase Fast Gnet GBC
Benzenamine,2-methyl-4-[2-(2-methylphenyl)diazenyl]
2',3-Dimethyl-4-aminoazobenzene
tulabasefastgnetgbc
4-(ORTHO-TOLYLAZO)-ORTHO-TOLUIDINE
MFCD00007733
Toluazotoluidine
2-Methyl-4-[(o-tolyl)azo]aniline
ortho-toluol-azo-ortho-toluidin[qr]
ORTHO-AZOAMINOTOLUENE
4μ-Amino-2,3μ-dimethylazobenzene, o-Aminoazotoluene, Solvent Yellow 3
2-methyl-4-[(2-methylphenyl)azo]-Benzenamine
FAST GNET GBC BASE
oilyellowi[qr]
P-Aminoazotoluene
o-Aminoazotoluene Solution, 100ppm
EINECS 202-591-2
oilyellowc[qr]
orthoaminoasotoluol
2’,3-dimethyl-4-aminoazobenzene
4-o-tolylazo-o-toluidine 4-amino-2',3-dimethylazobenzene fast gnet GBC base AAT o-aminoazotoluene
2-METHYL-4-((2-METHYLPHENYL)AZO)-BENZENAMIDE
Tulabase Fast Gnet GB
organolyellow2t
Somalia Yellow R
2’,3-dimethyl-4-aminoazobenzene[qr]
ortho-aminoazotoluene
sudanyellowrra[qr]
4'-Amino-2,3'-dimethylazobenzene
ortho-tolueneazo-ortho-toluidine[qr]
toluazotoluidine[qr]
TOLUENEAZOAMINOTOLUENE
2-methyl-4-((2-methylphenyl)azo)-benzenamin
2-methyl-4-((2-methylphenyl)azo)benzenamine
O-AMINOAZOTOLUENE
4μ-Amino-2,3μ-dimethylazobenzene, Solvent Yellow 3
2-methyl-4-((o-tolyl)azo)aniline[qr]
Organol Yellow 2T
oilyellowt
2-Methyl-4-[(E)-(2-methylphenyl)diazenyl]aniline
somaliayellowr[qr]
oilyellowi
Orthoaminoazotoluene
2-methyl-4-[(2-methylphenyl)azo]-benzenamin
O-TOLUENE-AZO-O-TOLUIDINE
Benzenamine, 2-methyl-4-(2-methylphenyl)azo
oilyellowc
o-Toluol-azo-o-toluidin
O-AMINOAZOTOLUENE OEKANAL
tulabasefastgnetgb[qr]
ORTHOAMINOAZOTOLUOL
tulabasefastgnetgb
o-Toluidine, 4-(o-tolylazo)
Description 2-Methyl-5-(p-tolyldiazenyl)aniline is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
Related Catalog
Density 1.09 g/cm3
Boiling Point 407.7ºC at 760 mmHg
Melting Point 101-102 °C
Molecular Formula C14H15N3
Molecular Weight 225.28900
Flash Point 200.4ºC
Exact Mass 225.12700
PSA 50.74000
LogP 4.88220
Index of Refraction 1.571

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XU8800000
CHEMICAL NAME :
o-Toluidine, 4-(o-tolylazo)-
CAS REGISTRY NUMBER :
97-56-3
BEILSTEIN REFERENCE NO. :
0745567
LAST UPDATED :
199712
DATA ITEMS CITED :
61
MOLECULAR FORMULA :
C14-H15-N3
MOLECULAR WEIGHT :
225.32
WISWESSER LINE NOTATION :
ZR B1 DNUNR B1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
800 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 gm/kg/57W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
480 mg/kg/I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
480 mg/kg female 17-19 day(s) after conception
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - transplacental tumorigenesis Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
800 mg/kg
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4000 mg/kg female 15-21 day(s) after conception
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Reproductive - Tumorigenic effects - transplacental tumorigenesis Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2800 mg/kg/28W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Multiple routes
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
400 mg/kg/I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
4500 mg/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5280 mg/kg/88D-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4000 mg/kg/39W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
31250 mg/kg/35W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3640 mg/kg/25W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
13440 mg/kg/32W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3200 mg/kg/35W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Gastrointestinal - tumors Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
480 mg/kg female 16-21 day(s) after conception
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Reproductive - Tumorigenic effects - transplacental tumorigenesis Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
34080 mg/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
480 mg/kg
SEX/DURATION :
multigeneration
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - hepatobiliary system Reproductive - Tumorigenic effects - transplacental tumorigenesis
TYPE OF TEST :
Unscheduled DNA synthesis
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
Sister chromatid exchange

MUTATION DATA

TYPE OF TEST :
Morphological transformation
TEST SYSTEM :
Non-mammalian species Cells - not otherwise specified
DOSE/DURATION :
250 ug/L
REFERENCE :
AOHYA3 Annals of Occupational Hygiene. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 20,297,1977 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 8,61,1975 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 8,61,1975 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW AEHLAU Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC 20016) V.1- 1960- Volume(issue)/page/year: 23,6,1971 TOXICOLOGY REVIEW ZEKBAI Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. Volume(issue)/page/year: 71,32,1968 TOXICOLOGY REVIEW ADCSAJ Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- Volume(issue)/page/year: 13,271,1970 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-FINLAND;Carcinogen JAN 1993 OEL-FRANCE;Carcinogen JAN 1993 OEL-GERMANY;Carcinogen JAN 1993 OEL-SWITZERLAND;Carcinogen JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1409 No. of Facilities: 200 (estimated) No. of Industries: 6 No. of Occupations: 14 No. of Employees: 3811 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1409 No. of Facilities: 229 (estimated) No. of Industries: 4 No. of Occupations: 5 No. of Employees: 1449 (estimated)
Symbol GHS07 GHS08
GHS07, GHS08
Signal Word Danger
Hazard Statements H317-H350
Precautionary Statements P201-P280-P308 + P313
Personal Protective Equipment Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges
Hazard Codes T: Toxic;
Risk Phrases R45;R43
Safety Phrases S53-S45
RIDADR UN 1789 8/PG 2
WGK Germany 3
RTECS XU8800000
HS Code 2927000090
HS Code 2927000090
Summary 2927000090 other diazo-, azo- or azoxy-compounds。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:97-56-3 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 97-56-3 | Chemsrc address: https://m.chemsrc.com/en/baike/683690.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2026 ChemSrc All Rights Reserved